Allergy News

1. New knee arthritis treatment delivers lasting pain relief without surgery

   A promising new treatment for knee arthritis uses tiny, dissolvable particles to block abnormal blood vessels, easing inflammation and pain without joint replacement surgery. In a study of 194 patients, 80% experienced clinically meaningful pain relief lasting at least 12 months.

2. Scientists may have overlooked a hidden Alzheimer's culprit for decades

   For decades, scientists have focused on amyloid beta as a major culprit behind Alzheimer’s disease, spending billions of dollars developing treatments that have often delivered disappointing results. Now, researchers at UC Santa Cruz are drawing attention to a largely overlooked peptide called P3 that could also play a role in the disease. Previously believed to be harmless, P3 can form harmful-looking protein clumps even faster than amyloid beta and may also damage brain cells.

3. Popular weight loss drugs linked to a surprising fingernail problem

   Popular GLP-1 weight loss drugs, such as Ozempic and Wegovy, have been linked to unexpectedly high rates of nail detachment, hair loss, and scalp inflammation, with some problems occurring several times more frequently among users. Researchers found that weight loss alone could not fully explain the differences, suggesting there may be more to these overlooked symptoms.

4. Scientists find hidden driver of aging and a simple amino acid that fights memory loss in mice

   Scientists discovered that declining levels of a protein called Menin may help drive aging, and restoring it in older mice reversed several age-related changes in just 30 days. Even more surprisingly, supplementing with a simple amino acid called D-serine improved memory and learning, offering a potential new approach to age-related cognitive decline.

5. New injection makes fat cells self-destruct

   Scientists have developed an experimental injection that destroys fat cells and significantly reduces dangerous belly fat, potentially opening a new path to treating obesity. Early research also suggests it could help prevent the weight regain that often follows stopping popular weight loss drugs like Ozempic and Wegovy.

6. Bowel cancer “melted away” after immunotherapy, then stayed away

   A short course of immunotherapy before surgery may offer remarkably durable protection for some patients with stage two or three bowel cancer. In the NEOPRISM-CRC trial, 32 patients with a specific genetic form of bowel cancer received pembrolizumab for up to nine weeks before surgery instead of the usual post-surgery chemotherapy. After nearly three years of follow-up, none of the patients had experienced a cancer recurrence, including those who still had small traces of disease after treatment.

7. Scientists may have found why diabetic wounds refuse to heal

   Chronic diabetic wounds may fail to heal because immune cells remain locked in damaging inflammatory states instead of transitioning toward tissue repair. Researchers are exploring treatments that reprogram these immune responses, raising hopes for more targeted and effective therapies for diabetic ulcers.

8. Goodbye joint replacements? Stanford scientists found a way to regrow cartilage and stop arthritis

   Scientists have found a surprising way to regrow damaged knee cartilage by blocking a protein that becomes more abundant with age. In old mice, the treatment restored naturally lost cartilage and also helped prevent osteoarthritis after ACL-like knee injuries, while human cartilage taken from knee replacement patients began producing new, functional joint cartilage after exposure to the same inhibitor.